American Century Companies’s Vir Biotechnology VIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.66M Buy
296,824
+1,433
+0.5% +$11.4K ﹤0.01% 2031
2025
Q4
$1.78M Sell
295,391
-626
-0.2% -$3.73K ﹤0.01% 2128
2025
Q3
$1.69M Buy
296,017
+22,309
+8% +$114K ﹤0.01% 2122
2025
Q2
$1.38M Buy
273,708
+16,088
+6% +$86.3K ﹤0.01% 2152
2025
Q1
$1.67M Buy
257,620
+26,896
+12% +$239K ﹤0.01% 2061
2024
Q4
$1.69M Buy
230,724
+23,835
+12% +$188K ﹤0.01% 2059
2024
Q3
$1.55M Buy
206,889
+38,654
+23% +$336K ﹤0.01% 2062
2024
Q2
$1.5M Buy
168,235
+18,967
+13% +$182K ﹤0.01% 2007
2024
Q1
$1.51M Buy
149,268
+49,897
+50% +$508K ﹤0.01% 1985
2023
Q4
$1,000K Sell
99,371
-1,363,938
-93% -$12.5M ﹤0.01% 2063
2023
Q3
$13.7M Sell
1,463,309
-16,251
-1% -$232K 0.01% 953
2023
Q2
$36.3M Buy
1,479,560
+116,067
+9% +$2.91M 0.03% 548
2023
Q1
$31.7M Buy
1,363,493
+309,573
+29% +$7.92M 0.03% 570
2022
Q4
$26.7M Buy
1,053,920
+493,599
+88% +$12.1M 0.02% 622
2022
Q3
$10.8M Buy
560,321
+397,675
+245% +$10.1M 0.01% 867
2022
Q2
$4.14M Buy
+162,646
New +$3.8M ﹤0.01% 1171

Other funds holding VIR